A phase I trial of human gamma interferon transduced autologous tumor cells in patients with disseminated malignant melanoma.
Seigler
H F
HF
Dept. Surgery, Duke University Medical Center, Durham, NC 27710.
Darrow
T L
TL
Abdel-Wahab
Z
Z
Gangavalli
R
R
Barber
J
J
D002985:Clinical Protocols; D004274:DNA, Recombinant / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D015316:Genetic Therapy / Q000009:adverse effects; D006801:Humans; D007371:Interferon-gamma / Q000235:genetics*; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009316:National Institutes of Health (U.S.); D015996:Survival Rate; D014161:Transduction, Genetic; D014481:United States
D004274:DNA, Recombinant; D007371:Interferon-gamma